Wu AH, Spicer D, Stanczyk FZ, Tseng CC, Yang CS, et al
The dosage and duration may vary depending on age, medical condition, and nutritional needs
Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results From the SURE UK Multicentre, Prospective, Observational Study
Signs of inadequate nutrition : If cold sensitivity occurs alongside dizziness, weakness, difficulty concentrating, or signs of malnutrition, your caloric intake may be insufficient
A personalized approach involves tracking symptom timing and metabolic markers (glucose, weight, appetite logs) across one or two weeks on your chosen schedule
Limitations of Use: Tirzepatide should not be used in combination with other tirzepatide-containing products or any other GLP-1 receptor agonist The safety and efficacy of coadministration with other products for weight loss have not been established Tirzepatide has not been studied in patients with a history of pancreatitis Tirzepatide should not be used in patients with type 1 diabetes mellitus Who should not use tirzepatide
